Novel Mechanisms Guide Innovative Molecular-Based Therapeutic Strategies for Fuchs Endothelial Corneal Dystrophy.

Cornea(2023)

引用 0|浏览4
暂无评分
摘要
Major advances in genomics have dramatically increased our understanding of Fuchs endothelial corneal dystrophy (FECD) and identified diverse genetic causes and associations. Biomarkers derived from these studies have the potential to inform both clinical treatment and yield novel therapeutics for this corneal dystrophy.
更多
查看译文
关键词
Fuchs endothelial corneal dystrophy, biomarkers, endothelial-mesenchymal transition (EndMT), genetics, epigenetics, protein misfolding
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要